Altimmune is rated a 'Sell' due to its lead drug pemvidutide lacking clear advantages in the competitive metabolic disease market and facing significant funding challenges despite a $480M cash reserve. The company's share count has doubled in a year, with more dilution expected. The ongoing Phase 3 trial's outcome is uncertain against established drugs like REZDIFFRA and WEGOVY. Other drug candidates have niche potential but high risks, adding to business uncertainty.
Altimmune's situation is presented here with Pluang's Health-sector market data for context. Of 150 priced Health-sector US stocks tradable on Pluang, 24 rose and 124 fell today. Notable movers include TWST at USD 113.30 with a -7.58% change, MRNA at USD 231.05 with a -7.09% change, and BFLY at USD 6.64 with a -7.00% change. This data is as of Nov 13, 2026 05:21 WIB.
Super League Enterprise, a company specializing in audience intelligence and media activation for the gaming industry, announced it will release its financial results for the third quarter ending September 30, 2026, on November 16, 2026, after market...
Stantec Inc. reported a 9.4% increase in net revenue to $1.9 billion for Q3 2026, driven by organic and acquisition growth. Adjusted EBITDA rose 16.6% to $377.1 million with a record margin of 20.2%, while adjusted EPS grew 23.5% to $1.89. The compan...
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
